Search Results 1051-1060 of 19808 for Hepatitis+C

1. Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis - Mayo Clinic

   Chronic active or acute viral hepatitis A, B, or C infection, or a hepatitis B or C carrier; Prior use of a JAK1 or JAK2 inhibitor; Use of chemotherapy ...

2. Study of Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder - Mayo Clinic

   Hepatitis B or C serologies consistent with past or current infections. Severe and/or symptomatic refractory concurrent infection other than EBV. Pregnant ...

3. Ethinyl estradiol and norgestimate (oral route) - Side effects & dosage - Mayo Clinic

   Do not use this medicine together with medicine to treat hepatitis C virus infection, including ombitasvir/paritaprevir/ritonavir, with or without dasabuvir ( ...

4. Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer - Mayo Clinic

   - Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on ...

5. Single-Ascending Dose Study of JK07 in Subjects With HFpEF - Mayo Clinic

   Positive screening for human immunodeficiency virus antibodies, hepatitis B surface antigen, or hepatitis C virus antibodies. 23. Known history of or active ...

6. A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies - Mayo Clinic

   Current hepatitis C infection (defined as positive HCV antibody and detectable HCV RNA. Participants with positive HCV antibody and undetectable HCV RNA are ...

7. Publications - Sahar Saddoughi, M.D., Ph.D. - Mayo Clinic

   Epub 2023 Apr 20. View PubMed; Saddoughi SA, Cypel M. Expanding the Lung Donor Pool: Donation After Circulatory Death, Ex-Vivo Lung Perfusion and Hepatitis C ...

8. Blood donation frequently asked questions - Mayo Clinic

   Anyone who in the past 3 months has had close contact with a person who has hepatitis B or hepatitis C. Close contact means you have lived with or had ...

9. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

   ... hepatitis C virus infection (see Appendix 3), autoimmune hepatitis, drug-induced hepatotoxicity, Wilson disease, α-1-antitrypsin deficiency, iron overload ...

10. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    Known history of chronic liver disease including cirrhosis, current alcohol abuse, or infection with hepatitis B virus or hepatitis C virus (active or carrier) ...